ONCS COVID-19 announcement fails to impress—stock down 16%: https://www.prnewswire.com/news-releases/oncosec-collaborates-with-providence-cancer-institute-to-conduct-first-in-human-trial-of-oncosecs-corvax12-an-investigational-vaccine-to-prevent-covid-19-combining-an-enhanced-spike-dna-sequence-and-tavo-301035810.html Caveat emptor: e.g. #msg-144697253, #msg-139759967.